←
Mazyar Shadman, MD MPH1,797 posts
Mazyar Shadman, MD MPH avatar✓

Mazyar Shadman, MD MPH ✓

@mshadman

Professor, CLL/Lymphoma. Targeted therapy , CAR-T & BsAbs. Deputy Chief Medical Officer, Medical Director,Cellular Immunotherapy, Fred Hutch and U of Washington

◷ Joined March 2009▧ 159 Photos and videos
Mazyar Shadman, MD MPH avatar
Mazyar Shadman, MD MPH@mshadman·Nov 5

Just published in @BloodJournal our @FredHutch investigator-initiated trial of CD20 CAR T in Waldenström macroglobulinemia—the largest reported CAR T series in WM. Developed in Brian Till’s lab; I had the privilege of serving as PI. The joy of bringing science from lab to clinic! ashpublications.org/blood/ar…… @IWMF_WM

Mazyar Shadman, MD MPH avatar
Mazyar Shadman, MD MPH@mshadman·Nov 13

Excited to support my friend and colleague Dr. @PGrivasMDPhD for the @ASCO Nominating Committee! A dynamic, visionary leader in GU oncology with tremendous passion, energy, and dedication to advancing cancer care. ASCO would be fortunate to have him in this role! @fredhutch

Post attachment
Tina Termini avatar
⟳ Mazyar Shadman, MD MPH retweeted
Tina Termini@CterminiPhD·Nov 6

I am excited to be a part of the inaugural cohort of @ASH_hematology-Amos Institute for Medical Faculty Development (AIMFD) scholars. This program is a masterclass of the power of embedding mentorship & community w/research support - major impact🩸 aimfd.org/2026/10/30/inaugur…

Post attachment
Vincent Rajkumar avatar
⟳ Mazyar Shadman, MD MPH retweeted
Vincent Rajkumar@VincentRK·Oct 16

This update which I do every 1-2 years is has usually been the most downloaded paper in AJH.

Post attachment
Mazyar Shadman, MD MPH avatar
Mazyar Shadman, MD MPH@mshadman·Oct 5

Interesting. And this may also bring to life all the pola containing second line options if we don't have to use pola in first line. Love the HR 0.49 Need to see the safety profile Logistics are still the main challenge

Post attachment